FDA approves Alzheimer’s drug Aduhelm, but concerns raised about cost, effectiveness

ABC15 2021-07-21

Views 8

The controversial, FDA-approved Alzheimer’s treatment has been met with concerns from health officials. In our latest video for Health Insider, Cronkite new breaks down what you should know about the new drug Aduhelm.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Breakthrough or risk FDA approves Alzheimer's drug
play
01:33

Breakthrough or risk FDA approves Alzheimer's drug
Taiwan FDA Panel Unanimously Approves Medigen Effectiveness Report - TaiwanPlus News
play
00:48

Taiwan FDA Panel Unanimously Approves Medigen Effectiveness Report - TaiwanPlus News
FDA approves new Alzheimer’s drug from Eli Lilly
play
01:30

FDA approves new Alzheimer’s drug from Eli Lilly
Breakthrough or risk FDA approves Alzheimer's drug
play
01:33

Breakthrough or risk FDA approves Alzheimer's drug
Breakthrough or risk FDA approves Alzheimer's drug
play
01:33

Breakthrough or risk FDA approves Alzheimer's drug
FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease
play
04:22

FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease
FDA approves Alzheimer's drug for further research
play
02:32

FDA approves Alzheimer's drug for further research
FDA approves controversial Biogen Alzheimer's drug _ DW News
play
03:30

FDA approves controversial Biogen Alzheimer's drug _ DW News
FDA Advisory Committee Unanimously Approves Eli Lilly's Alzheimer's Drug as Safe and Effective
play
00:29

FDA Advisory Committee Unanimously Approves Eli Lilly's Alzheimer's Drug as Safe and Effective
Breakthrough or risk FDA approves Alzheimer's drug
play
01:33

Breakthrough or risk FDA approves Alzheimer's drug
FDA approves controversial Biogen Alzheimer's drug _ DW News
play
03:30

FDA approves controversial Biogen Alzheimer's drug _ DW News
FDA Approves Promising New Alzheimer’s Drug Leqembi
play
01:03

FDA Approves Promising New Alzheimer’s Drug Leqembi